Fenoldopam-d4 mesylate

Modify Date: 2024-01-30 21:55:34

Fenoldopam-d4 mesylate structure	Common Name	Fenoldopam-d4 mesylate
	CAS Number	1246815-23-5	Molecular Weight	405.89
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₇H₁₆D₄ClNO₆S	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Fenoldopam-d4 mesylate

Fenoldopam-d4 (SKF-82526-d4) mesylate is the deuterium labeled Fenoldopam mesylate. Fenoldopam (SKF 82526) mesylate is a drug and synthetic benzazepine derivative which acts as a selective D1 receptor partial agonist[1][2].

Name	Fenoldopam-d4 mesylate

Description	Fenoldopam-d4 (SKF-82526-d4) mesylate is the deuterium labeled Fenoldopam mesylate. Fenoldopam (SKF 82526) mesylate is a drug and synthetic benzazepine derivative which acts as a selective D1 receptor partial agonist[1][2].
Related Catalog	Research Areas >> Cardiovascular Disease Signaling Pathways >> GPCR/G Protein >> Dopamine Receptor Signaling Pathways >> Neuronal Signaling >> Dopamine Receptor
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Grenader, A. and D.P. Healy, Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells. J Pharmacol Exp Ther, 1991. 258(1): p. 193-8. [3]. Nichols, A.J., R.R. Ruffolo, Jr., and D.P. Brooks, The pharmacology of fenoldopam. Am J Hypertens, 1990. 3(6 Pt 2): p. 116S-119S.

Molecular Formula	C₁₇H₁₆D₄ClNO₆S
Molecular Weight	405.89

Fenoldopam-d4 mesylate

Use of Fenoldopam-d4 mesylate

Names

Fenoldopam-d4 mesylate Biological Activity

Chemical & Physical Properties